Previous studies have found that HCP5 was shown to regulate neuroblastoma cells activation and promoted neuroblastoma progression by acting as ceRNA to bind with miR-186-5p and regulate MAP3K2 expression39. The gene discussed is MAP3K2; the disease is neuroblastoma.